|
1
|
Lim S and Park S: Role of vascular smooth
muscle cell in the inflammation of atherosclerosis. BMB Rep.
47:1–7. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Virmani R, Kolodgie FD, Burke AP, Farb A
and Schwartz SM: Lessons from sudden coronary death: A
comprehensive morphological classification scheme for
atherosclerotic lesions. Arterioscler Thromb Vasc Biol.
20:1262–1275. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rafieian-Kopaei M, Setorki M, Doudi M,
Baradaran A and Nasri H: Atherosclerosis: Process, indicators, risk
factors and new hopes. Int J Prev Med. 5:927–946. 2014.PubMed/NCBI
|
|
4
|
Bennett MR, Sinha S and Owens GK: Vascular
smooth muscle cells in atherosclerosis. Circ Res. 118:692–702.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rudijanto A: The role of vascular smooth
muscle cells on the pathogenesis of atherosclerosis. Acta Med
Indones. 39:86–93. 2007.PubMed/NCBI
|
|
6
|
Lusis AJ: Atherosclerosis. Nature.
407:233–241. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ross R: The pathogenesis of
atherosclerosis: A perspective for the 1990s. Nature. 362:801–809.
1993. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Crandall JP, Knowler WC, Kahn SE, Marrero
D, Florez JC, Bray GA, Haffner SM, Hoskin M and Nathan DM; Diabetes
Prevention Program Research Group: The prevention of type 2
diabetes. Nat Clin Pract Endocrinol Metab. 4:382–393. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou G, Myers R, Li Y, Chen Y, Shen X,
Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, et al: Role of
AMP-activated protein kinase in mechanism of metformin action. J
Clin Invest. 108:1167–1174. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ajjan RA and Grant PJ: Cardiovascular
disease prevention in patients with type 2 diabetes: The role of
oral anti-diabetic agents. Diab Vasc Dis Res. 3:147–158. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wan X, Huo Y, Johns M, Piper E, Mason JC,
Carling D, Haskard DO and Boyle JJ: 5′-AMP-activated protein
kinase-activating transcription factor 1 cascade modulates human
monocyte-derived macrophages to atheroprotective functions in
response to heme or metformin. Arterioscler Thromb Vasc Biol.
33:2470–2480. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Q, Zhang M, Torres G, Wu S, Ouyang C,
Xie Z and Zou MH: Metformin suppresses diabetes-accelerated
atherosclerosis via the inhibition of Drp1-mediated mitochondrial
fission. Diabetes. 66:193–205. 2017. View Article : Google Scholar :
|
|
13
|
Uitz E, Bahadori B, McCarty MF and
Moghadasian MH: Practical strategies for modulating foam cell
formation and behavior. World J Clin Cases. 2:497–506. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vigetti D, Clerici M, Deleonibus S,
Karousou E, Viola M, Moretto P, Heldin P, Hascall VC, De Luca G and
Passi A: Hyaluronan synthesis is inhibited by adenosine
mono-phosphate-activated protein kinase through the regulation of
HAS2 activity in human aortic smooth muscle cells. J Biol Chem.
286:7917–7924. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim SA and Choi HC: Metformin inhibits
inflammatory response via AMPK-PTEN pathway in vascular smooth
muscle cells. Biochem Biophys Res Commun. 425:866–872. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Storozhuk Y, Hopmans SN, Sanli T, Barron
C, Tsiani E, Cutz JC, Pond G, Wright J, Singh G and Tsakiridis T:
Metformin inhibits growth and enhances radiation response of
non-small cell lung cancer (NSCLC) through ATM and AMPK. Br J
Cancer. 108:2021–2032. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rufini A, Tucci P, Celardo I and Melino G:
Senescence and aging: The critical roles of p53. Oncogene.
32:5129–5143. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
McCubrey JA and Demidenko ZN: Recent
discoveries in the cycling, growing and aging of the p53 field.
Aging (Albany NY). 4:887–893. 2012. View Article : Google Scholar
|
|
19
|
Wang J, Deng Y, Tan Y, Li K, Wen B and
Zhao Q: Cannabinoid WIN55, 212-2 inhibits proliferation, invasion
and migration of human SMMC-7721 hepatocellular carcinoma cells. Xi
Bao Yu Fen Zi Mian Yi Xue Za Zhi. 32:619–624. 2016.In Chinese.
PubMed/NCBI
|
|
20
|
Li P, Zhao M, Parris AB, Feng X and Yang
X: p53 is required for metformin-induced growth inhibition,
senescence and apoptosis in breast cancer cells. Biochem Biophys
Res Commun. 464:1267–1274. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cerezo M, Tichet M, Abbe P, Ohanna M,
Lehraiki A, Rouaud F, Allegra M, Giacchero D, Bahadoran P,
Bertolotto C, et al: Metformin blocks melanoma invasion and
metastasis development in AMPK/p53-dependent manner. Mol Cancer
Ther. 12:1605–1615. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cai X, Hu X, Tan X, Cheng W, Wang Q, Chen
X, Guan Y, Chen C and Jing X: Metformin induced AMPK activation,
G0/G1 phase cell cycle arrest and the inhibition of growth of
esophageal squamous cell carcinomas in vitro and in vivo. PLoS One.
10:e01333492015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen HP, Shieh JJ, Chang CC, Chen TT, Lin
JT, Wu MS, Lin JH and Wu CY: Metformin decreases hepatocellular
carcinoma risk in a dose-dependent manner: Population-based and in
vitro studies. Gut. 62:606–615. 2013. View Article : Google Scholar
|
|
24
|
Zhuang Y and Miskimins WK: Cell cycle
arrest in metformin treated breast cancer cells involves activation
of AMPK, downregulation of cyclin D1, and requires
p27Kip1 or p21Cip1. J Mol Signal. 3:182008.
View Article : Google Scholar
|
|
25
|
Kim EJ, Park JI and Nelkin BD: IFI16 is an
essential mediator of growth inhibition, but not differentiation,
induced by the leukemia inhibitory factor/JAK/STAT pathway in
medullary thyroid carcinoma cells. J Biol Chem. 280:4913–4920.
2005. View Article : Google Scholar
|
|
26
|
Song LL, Alimirah F, Panchanathan R, Xin H
and Choubey D: Expression of an IFN-inducible cellular senescence
gene, IFI16, is upregulated by p53. Mol Cancer Res. 6:1732–1741.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Duan X, Ponomareva L, Veeranki S and
Choubey D: IFI16 induction by glucose restriction in human
fibroblasts contributes to autophagy through activation of the
ATM/AMPK/p53 pathway. PLoS One. 6:e195322011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
29
|
Vasamsetti SB, Karnewar S, Kanugula AK,
Thatipalli AR, Kumar JM and Kotamraju S: Metformin inhibits
monocyte-to-macrophage differentiation via AMPK-mediated inhibition
of STAT3 activation: Potential role in atherosclerosis. Diabetes.
64:2028–2041. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ding WX: Uncoupling AMPK from autophagy: A
foe that hinders the beneficial effects of metformin treatment on
metabolic syndrome-associated atherosclerosis? Focus on 'glucose
and palmitate uncouple AMPK from autophagy in human aortic
endothelial cells'. Am J Physiol Cell Physiol. 308:C246–C248. 2015.
View Article : Google Scholar
|
|
31
|
Rakesh K and Agrawal DK: Cytokines and
growth factors involved in apoptosis and proliferation of vascular
smooth muscle cells. Int Immunopharmacol. 5:1487–1506. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Selzman CH, Miller SA, Zimmerman MA,
Gamboni-Robertson F, Harken AH and Banerjee A: Monocyte chemotactic
protein-1 directly induces human vascular smooth muscle
proliferation. Am J Physiol Heart Circ Physiol. 283:H1455–H1461.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sarfstein R, Friedman Y, Attias-Geva Z,
Fishman A, Bruchim I and Werner H: Metformin downregulates the
insulin/IGF-I signaling pathway and inhibits different uterine
serous carcinoma (USC) cells proliferation and migration in
p53-dependent or -independent manners. PLoS One. 8:e615372013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Clarke CJ, Hii LL, Bolden JE and Johnstone
RW: Inducible activation of IFI 16 results in suppression of
telomerase activity, growth suppression and induction of cellular
senescence. J Cell Biochem. 109:103–112. 2010.
|
